Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP‐C Treatment as Prevention Study in Prisons-Reference-Cited by-同舟云学术

Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP‐C Treatment as Prevention Study in Prisons

Published:2021-08-22 Issue:5 Volume:74 Page:2366-2379
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lim Aaron G.¹^ORCID,Stone Jack¹^ORCID,Hajarizadeh Behzad²,Byrne Marianne²,Chambers Georgina M.³,Martin Natasha K.⁴,Grebely Jason²,Dore Gregory J.²^ORCID,Lloyd Andrew R.²,Vickerman Peter¹^ORCID

Affiliation:

1. Population Health Sciences Bristol Medical SchoolUniversity of Bristol Bristol United Kingdom

2. The Kirby InstituteUNSW Sydney Sydney NSW Australia

3. Centre for Big Data Research in Health University of New South Wales Sydney NSW Australia

4. Division of Global Public Health University of California San Diego San Diego CA

Funder

Gilead Sciences

National Health and Medical Research Council

National Institute for Health Research

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32002

Reference38 articles.

1. Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis

2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

3. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study

4. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scale-up of direct-acting antiviral treatment in prisons is both cost-effective and key to HCV elimination;Open Forum Infectious Diseases;2023-12-18

2. Evaluation of the antiedematogenic and anti-inflammatory properties of Ximenia americana L. (Olacaceae) bark extract in experimental models of inflammation;Biomedicine & Pharmacotherapy;2023-10

3. Hepatitis C;The Lancet;2023-09

4. Nationwide Hepatitis C Serosurvey and Progress Towards Hepatitis C Virus Elimination in the Country of Georgia, 2021;The Journal of Infectious Diseases;2023-03-18

5. Consensus recommendations on the management of hepatitis C in Australia's prisons;Medical Journal of Australia;2023-03-05